Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study

Nima Motamed1, Hossein Ajdarkosh2, Mohammad Hadi Karbalaie Niya2

  • 1Department of Social Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.

Clinical Cardiology
|April 14, 2022
PubMed

Insights

Continuous scoring systems for metabolic syndrome (MetS) better predict cardiovascular events than traditional definitions. SEM-based scoring systems show promise for predicting cardiovascular events in women.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Epidemiology

Background:

  • Traditional dichotomous definitions of metabolic syndrome (MetS) lack predictive power for cardiovascular events.
  • Continuous scoring systems offer a nuanced approach to defining MetS.
  • Evaluating novel scoring systems for cardiovascular risk prediction is crucial.

Purpose of the Study:

  • To assess the efficacy of continuous scoring systems versus traditional definitions in predicting cardiovascular events.
  • To compare the predictive abilities of different MetS scoring systems, including SEM-based and siMS methods.
  • To determine the utility of these systems in diverse populations, stratified by sex.

Main Methods:

  • Analysis of a population-based cohort study with 5147 participants aged 18+.
  • Follow-up period of 7 years to ascertain atherosclerotic cardiovascular disease (ASCVD) events.
  • Comparison of the Joint Interim Statement (JIS) definition of MetS with two scoring systems: SEM-based and siMS.

Main Results:

  • SEM-based scoring systems demonstrated a significant association with composite cardiovascular events in both men and women.
  • The traditional JIS definition of MetS showed no significant association with cardiovascular events.
  • Scoring systems exhibited acceptable predictive ability for cardiovascular events in women, but not in men.

Conclusions:

  • Continuous MetS scoring systems, particularly SEM-based ones, are independently associated with cardiovascular events.
  • These scoring systems offer improved cardiovascular risk prediction compared to dichotomous definitions.
  • SEM-based scoring systems show potential for predicting cardiovascular events in women.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
139
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
492
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
99
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
379
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
242
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
311